Catalyst Loses Fight Against FDA Approval Of Rival's Drug
A Florida federal judge axed Catalyst Pharmaceuticals Inc.'s suit claiming the U.S. Food and Drug Administration unlawfully approved a lower-cost version of a drug that treats a rare autoimmune disease, rejecting...To view the full article, register now.
Already a subscriber? Click here to view full article